239-713-9 | Sigma-Aldrich

TB051VM pET-23a-d(+) Vector Map

3 733 1025 1392 Pfl1108I 1 2299 PleI 6 317 1282 1767 2270 3359 3367 Psp5II 2 352 394 Psp1406I 4 713 2507 2880 3209 PstI 1 2526 PvuI 1 2651 PvuII 1 979 RcaI 2 2108 3116 RsaI 2 1194 2761 SacI 1 190 SalI

XP725 Antibody Number-Lot Number 071M4826

754 755 756 8.4 685 686 687 688 709 710 711 712 733 734 735 736 757 758 759 760 8.5 689 690 691 692 713 714 715 716 737 738 739 740 761 762 763 764 8.6 693 694 695 696 717

Drug Discovery Products & Services - Volume 1, 2014

423, 12-529 Casein Kinase 1γ2, active 14-712 3 12-423, 12-529 Casein Kinase 1γ3, active 14-713 3 12-423, 12-529 Casein Kinase 1δ (aa 1-294), active 14-520 3 12-423, 12-529 Casein Kinase

XP725 Antibody List Lot 129K4830

90 H1775 3320 HSP90AA1 M NP_001017963.2 y y y 377 IFI-16 I1659 3428 IFI16 M NP_005522.2 y n/d n/d 713 TIS7 T2576 3475 IFRD1 M NP_001007246.1 ,NP_001184008.1 ,NP_001184009.1 ,NP_001541.2 y y n/d 380 ILK

XP725 Antibody List Lot 129K4831

90 H1775 3320 HSP90AA1 M NP_001017963.2 y y y 377 IFI-16 I1659 3428 IFI16 M NP_005522.2 y n/d n/d 713 TIS7 T2576 3475 IFRD1 M NP_001007246.1 ,NP_001184008.1 ,NP_001184009.1 ,NP_001541.2 y y n/d 380 ILK

XP725 Antibody List Lot 089K4791

90 H1775 3320 HSP90AA1 M NP_001017963.2 y y y 377 IFI-16 I1659 3428 IFI16 M NP_005522.2 y n/d n/d 713 TIS7 T2576 3475 IFRD1 M NP_001007246.1 ,NP_001184008.1 ,NP_001184009.1 ,NP_001541.2 y y n/d 380 ILK

XP725 Antibody List

http://www.sigmaaldrich.com/ProductLookup.html?ProdNo=G7670&Brand=SIGMA� 3 9 3 9 3 9 3 9 3 9 3 9 3 9 T 3 3 9 3 9 334 HDAC-7 H6663 56233, 51564 HDAC7A,Hdac7a NP_062518.2,NP_057680.3 M y y n/d

List of Antibodies

www.sigmaaldrich.com/ProductLookup.html?ProdNo=T7076&Brand=SIGMA� 750 terminal L1 U5258 P y y y 713 TIS7 T2576 M y y n/d 714 Tumor Necrosis Factor Soluble Receptor II T1815 M y n/d n/d 715 Tob T2948

Research Focus - Volume 2, 2013

C-terminal fragment containing P3 (C83). The latter can then be cleaved by γ-secretase at residue 711 or 713 to release the P3 fragment. This pathway does not yield Aβ peptide. Hence, shunting APP towards the

XP725 Antibody List 013M4793

63923 TNN NP_071376.1 M y n/d n/d 712 Thimet Oligopeptidase 1 T7076 7064 THOP1 NP_003240.1 M y n/d n/d 713 TIS7 T2576 3475, 15982, 29596 IFRD1,Ifrd1 NP_001541.2,NP_038590.1,NP_062115.1 M y y n/d 714 Tumor Necrosis

XP725 Worksheet for Lot Number 071M4826

H7162 phosphoHistone H2AX pSer139 H5912711 4 3 5 7 712 4 3 5 8 phosphoHistone H2AX pSer139 H5912 713 4 3 6 1 Histone H3 pSer10 H6409 714 4 3 6 2 Histone H3 pSer10 H6409 715 4 3 6 3 Histone H3

Halal Certificate

FCC, FG W349909 B14710 HC-22SIYG69 712. HEXYL ACETATE 98%, FCC, FG W256501 A11596 HC-22SI6O41 713. HEXYL ACETATE NATURAL, 98%, FCC, FG W256528 A28594 HC-22SI3P58 714. HEXYL ALCOHOL W256706 C37180

Halal Certificate

FCC, FG W349909 B14710 HC-24SIZK71 712. HEXYL ACETATE 98%, FCC, FG W256501 A11596 HC-24SICL43 713. HEXYL ACETATE NATURAL, 98%, FCC, FG W256528 A28594 HC-24SIA560 714. HEXYL ALCOHOL W256706 C37180

Inhibitor Sourcebook 3rd Edition

fragment containing P3 and C83. The latter can then be cleaved by g-secretase at residue 711 or 713 to release the P3 fragment. This pathway does not yield Ab peptide. Hence, shunting APP towards the